Gadolinium, or gadodiamide, provides greater contrast between normal tissue and abnormal tissue in the brain and body during an MRI (Magnetic Resonance Imaging). After it is injected into a vein, Gadolinium causes abnormal areas to become very bright (enhanced) on the MRI, making them easier to see. Gadolinium is then rapidly cleared from the body by the kidneys.

Gadolinium has been known to cause Nephrogenic Systemic Fibrosis (NSF) in those   patients with pre-existing kidney disease. If a person's kidneys are not functioning properly, it is extremely unlikely that the amount of gadolinium that is injected will be eliminated from the body.  This makes it far more likely that a patient with pre-existing kidney disease will develop NSF/NSD if exposed to gadolinium based MRI contrast agents.

If you have legal concerns regarding Gadolinium contrast agent, call today at (800) 555-4011 for you free consultation, or you can contact us here.